By proceeding, you agree to our Terms of Use and Privacy Policy.
THE INDUSTRY’S LEADING EVENT IN EUROPE TO ACCELERATE THERAPEUTICS TO MARKET BY EXPEDITING R&D, IMPROVING CMC EFFICIENCY, AND BUILDING NEW PARTNERSHIPS Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to
Explore process-related impurities in synthetic oligonucleotides categorization and origin.
Discover strategies for expediting the development of synthetic therapeutic oligonucleotides through the application of platform approaches.
Network with industry leaders like Paul Nioi, Lidia Oostvogels, Knud Jensen, Sotirios Tsimikas, Dominik Altevogt and others.
We are the world’s leading producer of live events and digital communities, where professionals share knowledge and make connections to help them grow professionally and commercially.
Cytiva is a global life sciences leader with more than 7,000 associates across 40 countries dedicated to advancing and accelerating therapeutics.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face.
W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives.
EUROAPI cover both API Solutions and Contract Development and Manufacturing Organization CDMO. We provide expertise in Quality, Regulatory and Supply and have dedicated commercial teams for our clients around the globe.
The Swiss-based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Abzu was born from the desire to challenge the fundamental assumptions of contemporary, black box AI.
Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 60 y
As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess con
Tosoh Bioscience, Inc., based in South San Francisco, CA is a U.S. subsidiary of Tosoh Corporation's Bioscience Division, headquartered in Tokyo, Japan.
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services f
Axolabs, a growing company located in Kulmbach (Bavaria, Germany) and Berlin, is a member of the globally active LGC Group.
BioSpring is a leading industry expert in oligonucleotide science and technology, delivering products at all production scales that meet the highest quality standards for therapeutic and diagnostic applications spanning the complete lifecycle from di
CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products and associated Packaging Services.
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories.
Polymun is a private company performing contract development and manufacturing of biopharmaceuticals as well as liposomal/LNP formulations. The most recent and prominent examples is Polymun’s contribution to the Covid-19 vaccine of BioNTech/Pfizer.
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovato
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform
It's a time of incredible progress at DuPont — a time of momentum. It's the time for change makers, for the doers and pioneers, to create essential innovations the world needs. We aren’t just creating a better future, we’re working together to invent
It's a time of incredible progress at DuPont — a time of momentum. It's the time for change makers, for the doers and pioneers, to create essential innovations the world needs. We aren’t just creating a better future, we’re working together to invent a better now. So bring your best self and join us
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.